Explorations of treatment for choroidal neovascularization complicating epiretinal membrane secondary to traumatic choroidal rupture

Lei Du,Jia Chen,Ting Long,Anhuai Yang,Yiqiao Xing
DOI: https://doi.org/10.3760/cma.j.issn.2095-1477.2017.03.004
2017-01-01
Abstract:Objective To evaluate the efficacy of vitrectomy combine with anti-vascular endothelial growth factor (VEGF) therapy for choroidal neovascularization (CNV) and epiretinal membranes secondary to traumatic choroidal rupture.Methods Clinical data of 9 eyes of 9 cases of CNV and epiretinal membrane secondary to traumatic choroidal rupture were analysed retrospectively.After pars plana vitrectomy all cases received ranibizumab intravitreal injection at least 3 times.The follow-up was 6 months.Results All surgeries were performed smoothly.The postoperative best corrected visual acuity and metamorphopsia improved after 6 months (t =2.6044,P =0.019).The epiretinal membrane of macula was not obvious after surgery and the area of CNV regressed remarkably.This condition remained stable during 6 months followup.Conclusion Vitrectomy combined with anti-VEGF therapy may be feasible for CNV and epiretinal membranes secondary to traumatic choroidal rupture within 6 months follow-up.
What problem does this paper attempt to address?